BIS

ProShares UltraShort Nasdaq Biotechnology [BIS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIS Stock Summary

Top 10 Correlated ETFs

BIS

Top 10 Correlated Stocks

BIS

In the News

BIS Financial details

Company Rating
-
Market Cap
3.1M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.11
Dividend %
1.88%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
5.88%
SMA50
-
SMA100
20%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
16.37-26.51
52W High
-27%
52W Low
+18.63%
RSI
62
Rel Volume
0.48
Avg Volume
25.34K
Volume
12.12K
Perf Week
13.45%
Perf Month
17.45%
Perf Quarter
21.2%
Perf Half Y
24.79%
-
-
-
-
Beta
-1.27
-
-
Volatility
0.47%, 0.62%
Prev Close
5.92%
Price
18.98
Change
6.21%

BIS Financial Performance

BIS Dividend History

BIS Frequently Asked Questions

What is ProShares UltraShort Nasdaq Biotechnology stock symbol ?

ProShares UltraShort Nasdaq Biotechnology is a US stock and trading under the symbol BIS

What is ProShares UltraShort Nasdaq Biotechnology stock quote today ?

ProShares UltraShort Nasdaq Biotechnology stock price is $18.98 today.

Is ProShares UltraShort Nasdaq Biotechnology stock public?

Yes, ProShares UltraShort Nasdaq Biotechnology is a publicly traded company.

Something similar

Top by Market Cap
DHR-PB
EMBASSY.NS
V
MSFT
FXAIX
Top Correlated ETFs
LABD
VTIP
STIP
STPZ
PJSR.DE
Top Correlated Stocks
SON.LS
ENGI.PA
GZF.DE
TRYG.CO
TELIA1.HE
Similar Market Cap
PUD.TO
LOV
NVVEW
155900.KS
SRES.L

Company Profile

Financial Services Asset Management
  • Volume Average 25.34K
  • Market Capitalization 3.1M
  • Headquarters US
  • IPO Date 2010-04-09

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.